The biomarker discovery outsourcing services global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Biomarker Discovery Outsourcing Services Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The biomarker discovery outsourcing services market size has grown rapidly in recent years. It will grow from $12.53 billion in 2023 to $14.58 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to increasing disease burden, pharmaceutical R&D demand, the regulatory environment, cost-effective solutions, research collaboration, and globalization.
The biomarker discovery outsourcing services market size is expected to see rapid growth in the next few years. It will grow to $26.85 billion in 2028 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to personalized medicine expansion, AI and machine learning integration, precision oncology growth, biomarker validation services, regulatory support, targeted therapy demand, and patient-centric healthcare. Major trends in the forecast period include increased adoption of precision medicine, technological advancements, rising demand for companion diagnostics, expansion of drug development pipelines, emerging applications in non-traditional disease areas, integration of artificial intelligence (AI) and machine learning (ML), regulatory support and standardization, global market expansion, partnerships and collaborations, and a and a focus on cost-effectiveness and time efficiency.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report
Scope Of Biomarker Discovery Outsourcing Services Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Biomarker Discovery Outsourcing Services Market Overview
Market Drivers –
The rising focus on personalized medicine is expected to propel the growth of the biomarker discovery outsourcing services market going forward. Personalized medicine refers to healthcare that tailors medical treatment to the individual characteristics of each patient. The rise of personalized medicine is due to individual genetic, lifestyle, and environmental factors, resulting in precise healthcare outcomes that ultimately improve patient care and reduce adverse effects. Outsourcing biomarker discovery services facilitates the advancement of personalized medicine by providing tailored diagnostic and therapeutic solutions based on individual patients’ biological markers. For instance, in February 2024, according to a report published by the Personalized Medicine Coalition, a US-based organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing focus on personalized medicine drives the growth of the biomarker discovery outsourcing services.
Market Trends –
Major companies operating in the biomarker discovery outsourcing services market are focusing on developing multiplexed biomarker assays, such as the immunoproteomic discovery platform, to improve patient outcomes and advance the field of discovering biomarkers. An immunoproteomic discovery platform is a specialized system that combines immunology and proteomics to identify and analyze proteins related to the immune response. For instance, in October 2023, Sengenics Corporation LLC, a Singapore-based precision medicine company, launched the immunoproteomic discovery platform, a comprehensive protein microarray platform for analyzing autoantibodies associated with disease diagnosis and therapeutic intervention. The i-Ome Discovery platform was developed to advance immune biomarker discovery and development and support academic and clinical biopharmaceutical research teams seeking to better understand the dynamic interactions and relationships between proteins, the immune system, and disease.
The biomarker discovery outsourcing services market covered in this report is segmented –
1) By Type: Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, Surrogate Endpoints
2) By Discovery Phase: Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development, Biomarker Selection
3) By Therapeutic Area: Oncology, Cardiology, Neurology, Autoimmune Diseases, Other Therapeutic Areas
4) By End Use: Pharmaceutical Companies, Biotechnology Companies
Get an inside scoop of the biomarker discovery outsourcing services market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15741&type=smp
Regional Insights –
North America was the largest region in the biomarker discovery outsourcing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker discovery outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major companies operating in the biomarker discovery outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC, Crown Bioscience Inc.
Table of Contents
1. Executive Summary
2. Biomarker Discovery Outsourcing Services Market Report Structure
3. Biomarker Discovery Outsourcing Services Market Trends And Strategies
4. Biomarker Discovery Outsourcing Services Market – Macro Economic Scenario
5. Global Biomarker Discovery Outsourcing Services Market Size and Growth
.
.
.
32. Global Biomarker Discovery Outsourcing Services Market Competitive Benchmarking
33. Global Biomarker Discovery Outsourcing Services Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Biomarker Discovery Outsourcing Services Market
35. Biomarker Discovery Outsourcing Services Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
